Market closed

Palvella Therapeutics Inc/$PVLA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Palvella Therapeutics Inc

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Ticker

$PVLA
Trading on

Industry

Biotechnology

Employees

14

ISIN

US6979471090

PVLA Metrics

BasicAdvanced
$254M
-
-$7.83
-
-
$254M
$29.27
$18.23
87K
7.33
7.139
19.075
19.075
-3.26%
-18.39%
-59.37%
4.05
4.05
-4.731
-460.93%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PVLA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Palvella Therapeutics Inc stock?

What is the P/E ratio for Palvella Therapeutics Inc stock?

Does Palvella Therapeutics Inc stock pay dividends?

When is the next Palvella Therapeutics Inc dividend payment date?

What is the beta indicator for Palvella Therapeutics Inc?